Sunset clause – A list of medicinal products jeopardised by sunset clause

An overview of medicinal products that may be affected by the sunset clause, including the changes arising from the amended Act on Pharmaceuticals effective as of 2 April 2013 was published on 3 October 2016 .  

These medicinal products could be subject to the sunset clause pursuant to Section 34a (1) of Act No. 378/2007 Coll., on pharmaceuticals, as amended and pursuant to Section 34a (2) of Act No. 378/2007 Coll., on pharmaceuticals, as amended. 

The overview is for information purposes only and shall not be binding.

The marketing authorisation number, the code assigned by the Institute for Drug Control (SÚKL), name of the product, supplement, AT code, marketing authorisation holder, MRP number and status of the marketing authorisation shall be stated in the overview for each medicinal product.

xls.pngMedicinal product jeopardised by the SC to 31.12.2016.xls, soubor typu xls, (88.5 kB)

 

Marketing Authorisation Branch
April 18 2010

Update October 3 2016